Partner Therapeutics’ Bizengri is now FDA approved for treating advanced cases of cholangiocarcinoma driven by NRG1 gene fusions. Partner acquired U.S. rights to this bispecific antibody from Merus in 2024. The post A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy appeared first on MedCity News.
By embracing better tools and smarter approaches, agencies can reduce the strain on their teams and give their patients the most seamless, high-quality care possible. The post Critical Care Documentation: Why It’s Different and How It Impacts Patient Care appeared first on MedCity News.
For the triage nurse, it comes down to understanding nuance and unique patient needs, whether that’s identifying an acute condition or just lending a listening ear. The post Listen Closer: What Triage Nurses Hear That Others Miss appeared first on MedCity News.
A comment docket dominated by hospital lobby framing produces a rule that reflects that framing. A comment docket that includes documented employer cost analysis, physician ownership experience, and market structure argument produces a different rule. The post The Most Consequential Healthcare Market Structure Question of the Next Decade Is Sitting in a Comment Docket —…
The autism care system in the U.S. needs stronger accountability and transparency. But it also needs new models that can deliver higher-quality care to more families, more efficiently, and regardless of where they live. The post Autism Therapy is in Dire Need of a New Business Model appeared first on MedCity News.
[Sponsored] A webinar sponsored by Verato and scheduled for May 27 will explore how a unified identity strategy, spanning patients, providers, and emerging solutions like Verato Identity Network enables accurate attribution, strengthens interoperability, and ultimately drives VBC success. The post Building a Unified Identity Strategy so Interoperability for Value-Based Care Can Succeed appeared first on…
An independent orthopedic surgeon in New York is claiming that he is being unfairly pushed out of a regional hospital owned by Mount Sinai Health System. The post Was Mount Sinai’s Victory in a Dispute Over a Physician’s Credentialing Worth It? appeared first on MedCity News.
Immunology-focused Windward Bio raised a mega-round of financing to support a lead program in development for respiratory disorders and a second program that could find use in respiratory and dermatological indications. Both drugs are long-acting antibodies that offer a dosing edge over currently available biologic medicines. The post Windward Bio Secures $165M for Clinical Trials…
The Department of Justice’s new “West Coast” strike force targets Arizona, Nevada and Northern California — regions flagged for rising Medicaid, hospice and tech-enabled fraud risks. Legal experts say the effort signals a broader shift toward data-driven enforcement, as regulators ramp up their scrutiny of telehealth companies and billing automation software. The post DOJ Doubles…
By investing upfront in a more highly trained homecare workforce, states can avoid the massive costs associated with acute interventions and admissions to hospitals and residential facilities. The post States are Advancing Homecare’s Next Big Step — Paying Caregivers for Skill, Not Just Time appeared first on MedCity News.